Medifast, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2024: USD 39.95 M

Medifast, Inc. Operating Cash Flow is USD 39.95 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -78.85% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Medifast, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 188.87 M, a 39.52% change year over year.
  • Medifast, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 135.37 M, a 11.11% change year over year.
  • Medifast, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 121.83 M, a -15.70% change year over year.
  • Medifast, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 144.52 M, a 79.64% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities